21 June 2019
Completion of formation of a new Joint Venture with BRAVO and acquisition…
20 June 2019
Trading Update and Statement Regarding a Possible Offer…
19 June 2019
Q1 FY20 Trading Update
18 June 2019
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer…
17 June 2019
Results for the six months to 30 April 2019…
Calquence significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia…
14 June 2019
Annual General Meeting
13 June 2019
Board Change